A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea (FX2016-11)
Phase of Trial: Phase III
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Minocycline (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Foamix
- 12 Jun 2017 Status changed from not yet recruiting to recruiting according to a Foamix media release.
- 12 Jun 2017 According to a Foamix media release, the company expects to report top-line results from the blinded phase of this trial by mid-2018.
- 04 May 2017 Status changed from planning to not yet recruiting.